Live Breaking News & Updates on Michaelj Morris

Stay updated with breaking news from Michaelj morris. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

JNJ-6420 Elicits Responses in mCRPC, But Safety Concerns Arise

A novel radioligand therapy, JNJ-6420, demonstrates potential in treating mCRPCr, delivering sustained responses following only 1-2 doses. ....

Michaelj Morris , Memorial Sloan Kettering Cancer Center , Division Of Solid Tumor Oncology , Solid Tumor Oncology ,